Related Experiment Video
Updated: Feb 16, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Adverse Effects on β-Adrenergic Receptor Coupling: Ischemic Postconditioning Failed to Preserve Long-Term Cardiac
Rolf Schreckenberg1, Péter Bencsik2,3, Martin Weber4
1Physiologisches Institut, Justus-Liebig-Universität Gießen, Gießen, Germany rolf.schreckenberg@physiologie.med.uni-giessen.de.
Ischemic preconditioning (IPC) and postconditioning (IPoC) protect the heart initially, but only IPC improves long-term heart function by preserving beta-adrenergic receptor signaling. IPoC leads to heart failure due to receptor desensitization.
Area of Science:
- Cardiology
- Physiology
- Molecular Biology
Background:
- Ischemic preconditioning (IPC) and postconditioning (IPoC) are effective cardioprotective strategies against ischemia/reperfusion injury.
- The long-term effects of IPC and IPoC on functional recovery and receptor-mediated signaling in the postischemic heart remain unclear.
Purpose of the Study:
- To investigate the impact of IPC and IPoC on the regulation and coupling of beta-adrenergic receptors.
- To assess the effects of these interventions on postischemic left ventricular function and signaling pathways.
Main Methods:
- Analysis of beta-adrenergic signal transduction in Wistar rats subjected to sham operation, ischemia/reperfusion, IPC, or IPoC.
- Assessment of infarct size, apoptosis, reactive oxygen species production, and myocardial tissue preservation immediately after infarction.
- Evaluation of fractional shortening and response to beta-adrenergic stimulation 7 days post-myocardial infarction.
Main Results:
- Both IPC and IPoC reduced infarct size, apoptosis, and reactive oxygen species, preserving myocardial tissue immediately after infarction.
- Seven days post-infarction, only IPC hearts showed significant functional improvement.
- IPoC hearts exhibited deteriorated fractional shortening and inadequate response to beta-adrenergic stimulation due to beta-adrenergic receptor kinase-2 stabilization.
Conclusions:
- Transient activation of beta-adrenergic receptor kinase-2 may offer short-term protection.
- Long-term induction and stabilization of beta-adrenergic receptor kinase-2, as seen with IPoC, leads to beta-adrenergic receptor desensitization and heart failure symptoms.
Related Concept Videos
Heart Failure Drugs: β-Blockers
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Heart Failure II: Pathophysiology

